The Cassation Economic Court as a part of the Supreme Court ruled on the final decision in the case on terminating the violation of intellectual property rights of JSC “Farmak” to the well-known trademark “Corvalol”
The Court dismissed the cassation appeal of PC “Zdorovye” LLC and upheld the decisions of the court of first instance and the court of appeal. The decision of the court of first instance which was upheld by the Northern Economic Court of Appeal cancelled the Order of the Ministry of Health of Ukraine on the registration of the medicinal product “Corvalol-Zdorovye”, obliged the Ministry of Health of Ukraine to exclude the medicinal product “Corvalol-Zdorovye” from the State Register of Medicinal Products of Ukraine and banned PC “Zdorovye” LLC from using designation “Corvalol-Zdorovye”.
The trial has lasted for almost 2 years.
Just to remind you, Corvalol Corvalolum remains a well-known designation. The Grand Chamber of the Supreme Court has filed a dispute case for a well-known Corvalol Corvalolum TM for a new trial to the court of first instance, partially satisfying the cassation appeal of the Ministry of Economic Development and Trade of Ukraine and JSC “Farmak”, by revoking the decision of the Court of Appeal and the decision of the court of first instance.
The pharmaceutical company JSC “Farmak” considers the possibility of launching the manufacture of products, in particular, diagnostic test kits, to combat coronavirus spread. “Now we analyse the possibility of arranging the release of supportive care products, disinfectants and antiseptics, diagnostic test kits, protective medical products, including masks, ...
Farmak reinvests 95% of its profits in the development. “We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a […]
The Memorandum is aimed at developing the mutual cooperation in the implementation of the state programs of the Republic of Uzbekistan for the further development of the national pharmaceutical industry. “We know the Uzbek market well and we are committed to develop cooperation. Farmak has been present in Uzbekistan since 2004. The residents of this [&hellip...